Together | Equity Crowdfunding - Information regarding UpnRide Robotics Ltd

In the realm of groundbreaking inventions, there emerges a game-changing innovation that marks the dawn of a new era. Presenting the smart robotic wheelchair, a remarkable creation that grants individuals paralyzed from the neck down the extraordinary ability of complete upright mobility. This cutting-edge technology ushers in a paradigm shift, empowering individuals with severe mobility limitations to regain independence and navigate the world on their terms. The smart robotic wheelchair represents a big leap forward, revolutionizing the lives of those previously confined by paralysis.

Type Stocks

Category Medical Device

Minimum Investment 0

The Story Behind the Product

After ReWalk, the solution that enabled paraplegic individuals to stand up and walk, the winning team at ReWalk Robotics does it again – enabling upright mobility to quadriplegic individuals.

The lives of millions are about to change thanks to this invention that will remove social barriers and allow eye level contact for the first time. Boosting self-esteem and general health, which is severely impaired due to extended sitting, and materially improving quality of life. And this is only the beginning: the revolutionary company intends to use the investment proceeds to continue developing more advanced models, with maneuvering capabilities that will afford access to difficult and more complicated places.

This is precisely the kind of company that has awarded us the title of Startup Nation, and this time you are among the lucky individuals to learn about this amazing invention before everyone else, and an opportunity to invest in the company just as it bursts into the market.

Do you want to invest in the future of humanity? The solution is right in front of you.

The Product

UPnRIDE is a smart robotic wheelchair, which for the first time ever allows complete upright mobility for individuals paralyzed from the neck down.

The chair is controlled by complex algorithms developed over a period of several years (registered patents), which create an automatic balancing system, allowing transition from sitting to standing at a push of a button, and unlimited mobility on inclines, slopes and other terrain.

Principal Features:

A system of belts and straps providing full and safe support for users without the ability to move
The automatic center of gravity balancing system guarantees continued stability even on slopes
Driven by sophisticated algorithms that minimize risks of dangerous situations
Thin and durable allowing easy maneuverability

Advantages

Allows outdoor mobility – the automatic balancing system promises safe travel up and down slopes and on gradient surfaces. Capable also off-road and in less than optimal conditions.
Reduces medical costs – avoid medical treatment, medication, and physiotherapy required due to prolonged sitting.
Offers a comprehensive solution for quadriplegic individuals, paralyzed from the neck down, and to those suffering from limited mobility. Suitable for most wheelchair users.

The registered patents afford the company the ability to maintain its technological advantage for years to come, a fact that makes the company a “life changer” and presenting a once-in-a-life-time investment opportunity with significant financial potential.

Market and Potential

Target audience:

1 out of 100 individuals in the western world is strapped to a wheelchair. We are talking about a population of approx. 70 million which continues to grow.
The company has a waiting list of 2,000 potential buyers for the product from around the world.
The chair attracts interest and amazement from all over the world, creating fascination in the fields of medicine, physiotherapy, and research, and is sought after by the U.S. Department of .Veterans Affairs

In addition, the product presents a solution for global problems shared by:

Insurance companies – life in a wheelchair is a source of consistent deterioration in the physical and mental condition of the disabled person, costing insurance companies up to 200,000 USD per year.
Governments – immobility caused by life in a wheelchair leads to unemployment and a significant loss of revenues in the economy of approx. 100,000 USD per year for each disabled person in a standard wheelchair.

Improving mobility options coupled with the ability to leave home in an upright position significantly improves both physical and mental health, boosts social and personal life and saves hundreds of thousands of dollars per year for the disabled person, insurance companies and governments.

Alternatives and Competitors

The company has proprietary patented technology and intellectual property, after having advanced previously existing technology by several generations and exhibiting a significant leap forward. Currently, there are no other companies exhibiting similar capabilities.

Product Status and Forecast

Status

The product itself is ready. The company is now engaged in sales and establishing a worldwide distribution network.

Simultaneously, the company continues investing efforts in research and development of its products, in order to remain on the cutting edge in its field.

Distribution

The company is currently supplying samples of UPnRIDE chairs to the U.S. military who is showing great interest in the company as a good solution for its disabled veterans. This is a preliminary stage for gaining access to the U.S. market following FDA approval.

At the same time, the company is establishing a worldwide distribution network, having executed distribution agreements in the U.K. and Hong Kong and conducting advanced negotiations with other leading countries.

The company’s objective is listing on NASDAQ similar to the company’s previous solution – ReWalk. On top of the potential for profit, the product’s ability to change the lives of millions is a strong and stable anchor.

The forecast is for the product to quickly become a standard with disabled individuals around the world. Similar to when every disabled person had a wheelchair that has over the years evolved into a motorized chair.

Anticipated retail price for end users: approx. 30,000 USD.

A few words from the company’s founder, Dr. Amit Goffer

Imagine how difficult it is to be an adult seeing the world from the height of a six-year-old child. When the counter is always too high, when everyone looks down on you, even young people.

UPnRIDE is here to remind everyone that disabled people are right here with us at eye level. This is investable and natural evolution, leading to developing the perfect product.

Q&A

What do sitting and smoking have in common? And why is it so important to stand up?

The idea for developing the product was triggered by the notion that sitting is the new smoking. Watch the following clip to understand a little more about this revelation:

The importance of movement is widely acknowledged. Extended sitting is related to poor metabolic health, heart disease, and high sugar and triglyceride levels. These variables accelerated the need to develop a revolutionary product to help disabled individuals improve their ability to move.

What is the product’s unique “organic marketing potential”?

There is a wide range of equipment and medical devices in various fields meant to provide solutions for various diseases and disabilities. One of the most significant advantages of UPnRIDE is that the chair will be visible on the street, at restaurants, at the grocery store or anywhere else you go. This exposure alone is the best kind of marketing: as soon as a disabled person or family member sees UPnRIDE for the first time, the image will be memorable and warrant an immediate recommendation to any other disabled person they know, exposing the innovative technology that will change their lives. Nothing can beat that!

About the Company

The company was established to provide a smart robotic solution for millions of disabled persons – to improve health and quality of life, make mobility easier and reduce social barriers.

The company’s management and board of advisors include successful entrepreneurs and accomplished engineers with expertise in technology driven ventures, finances, health, physical rehabilitation, bio-medical engineering and wheelchair manufacturing, as well as leading companies to listing on NASDAQ.

Global media applauds the company, which was chosen as one of the promising companies in the area of improving life of disabled individuals and was recommended by renowned influencers.

The company is held in high acclaim throughout the world and considered a pioneer in the field of robotic wheelchairs, also according to international market research

(https://www.researchandmarkets.com/research/74bxtp/global_robotic?w=4)

Technologies, patents and registered property

The company has registered many patents around the world, including on the lifting mechanism and balancing mechanism – which constitutes a material technological advantage, allowing the chair to safely leave the home, contrary to existing solutions that are limited to household use and only work on flat surfaces.

The company’s knowledge, experience and patents boil down to a product that is in a class of its own.

The company has obtained CE approval from the European Medicines Agency and has completed its submissions to the U.S. Food and Drug Administration (FDA).

Oren Tamari - Founder and CEO

Before his current position, Oren was the CEO of ReWalk Robotics and together with Dr. Goffer took the company from prototype to worldwide sales and ready to be listed on NASDAQ. Before that Oren founded and managed technology companies, was involved in international business development, served as Economic Attaché in Singapore and managed multidisciplinary R&D projects for the military. Oren holds a bachelor’s degree in engineering from the Technion and an MBA from Tel Aviv University.

Dr. Amit Goffer - Founder, president and CTO

First, Dr. Goffer developed ReWalk for paraplegic individuals, helping them stand up, walk and complete a marathon – and the company successfully listed on NASDAQ. Then Dr. Goffer started to develop UPnRIDE, which provides a solution for nearly the entire disabled population and expected to help millions of disabled individuals to stand up for the first time in their lives. Dr. Goffer is extremely experienced and a world class expert in his field, able to change the lives of millions while leading the company to attain its goals.

Dudu Haimovich - Chief Engineer and Founder

Dudu is the owner and manager of DH Engineering and has been engaged in medical technology and manufacturing for more than 30 years, including ReWalk, and is the owner of a number of patents in the medical and communications fields.

Realization Strategy

UPnRIDE is positioned as a life changing product, allowing upright mobility, that improves health, builds self-esteem and social acceptance, saves on medical expenses, and all for a relatively reasonable price. This positioning allows easy access to an area that is extremely traditional and uncreative, taking a market share that will continue to grow, and becoming a leading player to increase the company’s value.

How will the company realize its long-term vision?

The company will act on several levels to attain its objectives:

Exposing the new technology and its advantages through the international media and exhibitions.
Appointing distributers specializing and specialty wheelchairs in the principal markets.
Conducting clinical studies to prove the advantages of UPnRIDE over existing wheelchairs and later convincing insurance companies to pay for it.
Establishing a serial production line for reducing costs and increasing competitiveness.
Engaging with large wheelchair manufacturers for examining cooperation, merger or acquisition.

Milestones

The next milestones for the company:

Completing the establishment of the marketing system for countries that recognize CE certification – mid-2019
Obtaining FDA approval and establishing a marketing system in the U.S. – beginning of 2019
Choosing a subcontractor and establishing a serial production line – end of 2018
Developing new models – continuous

Use of Financing Proceeds

The financing proceeds shall be used for the following purposes:

Establishing an international marketing and distribution network, first in Europe and countries that recognize CE certification, and later in the U.S. following FDA approval.
Conducting clinical studies to prove UPnRIDE’s advantages (medical, quality of life, self-esteem and cost saving).
Establishing a serial production line with a subcontractor.
Developing new models and product to always be ahead of potential competitors.

Leading Investors

The combination between a most worthy purpose and an extraordinary investment opportunity attracts many investors.

Initially, the company was funded by the founders and a few private investors, who believed in the cause, in the product and in the team, and later were joined by additional investors with extensive experience in business and technology.

The seal of approval for technological and marketing feasibility for the venture was granted by the State through an R&D grant of one million shekels, which greatly contributed to development and fund raising, and an approval was recently received for another significant grant.

Private investors were joined by the Our Crowd fund, providing the seal of approval of a leading institutional investor, which has already invested in more than 100 groundbreaking technological ventures. The fund has to date invested significant amounts and shall also participate in the present round.